Clinical Trials Logo

Citation(s)

A Phase II Trial of CD24Fc for Prevention of Acute Graft-versus-Host Disease Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplant

Details for clinical trial NCT02663622